Further, in syngeneic CI-competent cancer models (NDUFS3+/+) we found that metformin treatment induces apoptosis at concentrations at which CI is not fully inhibited, indicating that the antiproliferative effects of this drug result also from the inhibition of other targets. The gene discussed is NDUFS3; the disease is cancer.